THE COMPLEMENT-MEDIATED BUT NOT MANNOSE RECEPTOR-MEDIATED PHAGOCYTOSIS IS INVOLVED IN THE HEPATIC-UPTAKE OF CETYLMANNOSIDE-MODIFIED LIPOSOMES IN-SITU

Citation
H. Matsuo et al., THE COMPLEMENT-MEDIATED BUT NOT MANNOSE RECEPTOR-MEDIATED PHAGOCYTOSIS IS INVOLVED IN THE HEPATIC-UPTAKE OF CETYLMANNOSIDE-MODIFIED LIPOSOMES IN-SITU, Journal of drug targeting., 2(2), 1994, pp. 141-146
Citations number
27
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
1061186X
Volume
2
Issue
2
Year of publication
1994
Pages
141 - 146
Database
ISI
SICI code
1061-186X(1994)2:2<141:TCBNMR>2.0.ZU;2-D
Abstract
In the elimination of injected liposomes in vivo, it is considered tha t several serum components play an important role on hepatic uptake of them. This study was conducted to clarify the hepatic uptake mechanis m of cetylmannoside (Man)-modified multilamellar vesicles (Man-MLV) us ing perfused rat liver. In the presence of serum, Man-MLV was taken up by the liver depending on the serum concentration, and it showed an a pproximately two-fold higher accumulation than MLV without any surface modifications (PC-MLV). These heptic uptakes of liposomes were obviou sly inhibited by preheating the serum at 56-degrees-C for thirty minut es or by the treatment with anti-rat C3 antiserum. Further, SDS-PAGE f ollowed by immunoblot analysis showed the deposition of iC3b on the op sonized Man-MLV. These results obtained in the present study suggested that hepatic uptake of Man-MLV was mainly mediated by complement rece ptor rather than mannose receptor on Kupffer cells in vivo.